Phenotyping of an in vitro model of ischemic penumbra by iTRAQ-based shotgun quantitative proteomics

Journal of Proteome Research

Volumn 9, Issue 1, 2010, Pages 472-484

  Datta, Arnab ^a   Park, Jung Eun ^a   Li, Xin ^a   Zhang, Huoming ^a   Ho, Zhi Shan ^a   Heese, Klaus ^a   Lim, Sai Kiang ^b   Tam, James P ^a   Sze, Siu Kwan ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

B104 cell line; Ischemic penumbra; iTRAQ; Mitochondrial permeability transition; Neuroproteomics; Oxygen glucose deprivation

Indexed keywords

DJ 1 PROTEIN; LACTATE DEHYDROGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL HYPOXIA; CONTROLLED STUDY; DISEASE MODEL; IN VITRO STUDY; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN ISCHEMIA; CELL LINE, TUMOR; FLOW CYTOMETRY; ISOTOPE LABELING; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PEPTIDE MAPPING; PHENOTYPE; PROTEOMICS; RATS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 73649107287     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900829h     Document Type: Article

References (58)

1. Zaleska, M. M.; Mercado, M. L. T.; Chavez, J.; Feuerstein, G. Z.; Pangalos, M. N.; Wood, A. The development of stroke therapeutics: Promising mechanisms and translational challenges. Neuropharmacology 2009, 56, 329-341.
2. + at critical levels of brain ischemia. Stroke 1977, 8 (1), 51-57.
3. Lo, E. H. A new penumbra: Transitioning from injury into repair after stroke. Nat. Med. 2008, 14 (5), 497-500.
4. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17 (10), 994-999.
5. Martin, B.; Brenneman, R.; Becker, K. G.; Gucek, M.; Cole, R. N.; Maudsley, S. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: Understanding the interface between physiology and disease. PLoS ONE 2008, 3 (7), e2750.
6. Tweedie-Cullen, R. Y.; Wollscheid, B.; Livingstone-Zatchej, M.; Mansuy, I. M. Neuroproteomics and the detection of regulatory phosphosites. Curr. Proteomics 2007, 4 (4), 209-222.
7. Miglio, G.; Varsaldi, F.; Francioli, E.; Battaglia, A.; Canonico, P. L.; Lombardi, G. Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia. Eur. J. Pharmacol. 2004, 489 (3), 157-165.
8. Bonde, C.; Noraberg, J.; Noer, H.; Zimmer, J. Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures. Neuroscience 2005, 136 (3), 779-794.
9. Lin, C. H.; Cheng, F. C.; Lu, Y. Z.; Chu, L. F.; Wang, C. H.; Hsueh, C. M. Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors. Exp. Neurol. 2006, 201 (1), 225-233.
10. Bottenstein, J. E.; Sato, G. H. Growth of a rat neuroblastoma cell line in serum free supplemented medium. Proc. Natl. Acad. Sci. U.S.A. 1979, 76 (1), 514-517.
11. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65 (1-2), 55-63.
12. Legrand, C.; Bour, J. M.; Jacob, C.; Capiaumont, J.; Martial, A.; Marc, A.; Wudtke, M.; Kretzmer, G.; Demangel, C.; Duval, D.; Hache, J. Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker. J. Biotechnol. 1992, 25 (3), 231-243.
13. Petronilli, V.; Miotto, G.; Canton, M.; Brini, M.; Colonna, R.; Bernardi, P.; Di Lisa, F. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 1999, 76 (2), 725-734.
14. Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 1995, 184 (1), 39-51.
15. Chong, P. K.; Gan, C. S.; Pham, T. K.; Wright, P. C. Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: Implication of multiple injections. J. Proteome Res. 2006, 5 (5), 1232-1240.
16. Seo, S. Y.; Kim, E. Y.; Kim, H.; Gwag, B. J. Neuroprotective effect of high glucose against NMDA, free radical, and oxygen-glucose deprivation through enhanced mitochondrial potentials. J. Neurosci. 1999, 19 (20), 8849-8855.
17. Tsujimoto, Y.; Shimizu, S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007, 12 (5), 835-840.
18. Nakagawa, T.; Shimizu, S.; Watanabe, T.; Yamaguchi, O.; Otsu, K.; Yamagata, H.; Inohara, H.; Kubo, T.; Tsujimoto, Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434 (7033), 652-658.
19. 2-Cells during islet-like differentiation using iTRAQ labeling. J. Proteome Res. 2009, 8 (3), 1393-1403.
20. Chee, S. G.; Poh, K. C.; Trong, K. P.; Wright, P. C. Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J. Proteome Res. 2007, 6 (2), 821-827.
21. Glen, A.; Gan, C. S.; Hamdy, F. C.; Eaton, C. L.; Cross, S. S.; Catto, J. W. F.; Wright, P. C.; Rehman, I. ITRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression. J. Proteome Res. 2008, 7 (3), 897-907.
22. Hata, R.; Maeda, K.; Hermann, D.; Mies, G.; Hossmann, K. A. Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 2000, 20 (2), 306-315.
23. Paschen, W.; Proud, C. G.; Mies, G. Shut-down of translation, a global neuronal stress response: Mechanisms and pathological relevance. Curr. Pharm. Des. 2007, 13 (18), 1887-1902.
24. Deocaris, C. C.; Kaul, S. C.; Wadhwa, R. From proliferative to neurological role of an hsp70 stress chaperone, mortalin. Biogerontology 2008, 9 (6), 391-403.
25. Kaufman, R. J. Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls. Genes Dev. 1999, 13 (10), 1211-1233.
26. Lo, E. H.; Dalkara, T.; Moskowitz, M. A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003, 4 (5), 399-415.
27. Lo, E. H.; Moskowitz, M. A.; Jacobs, T. P. Exciting, radical, suicidal: How brain cells die after stroke. Stroke 2005, 36 (2), 189-192.
28. Takagi, Y.; Tokime, T.; Nozaki, K.; Gon, Y.; Kikuchi, H.; Yodoi, J. Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: Immunohistochemical and hybridization studies of thioredoxin. J. Cereb. Blood Flow Metab. 1998, 18 (2), 206-214.
29. Hattori, I.; Takagi, Y.; Nozaki, K.; Kondo, N.; Bai, J.; Nakamura, H.; Hashimoto, N.; Yodoi, J. Hypoxia-ischemia induces thioredoxin expression and nitrotyrosine formation in new-born rat brain. Redox Rep. 2002, 7 (5), 256-259.
30. 2+ homeostasis. Brain Res. 2008, 1233 (C), 63-78.
31. Pignataro, G.; Scorziello, A.; Di Renzo, G.; Annunziato, L. Post-ischemic brain damage: Effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy. FEBS J. 2009, 276 (1), 46-57.
32. Flower, R. J. Lipocortin. Prog. Clin. Biol. Res. 1990, 349, 11-25.
33. Eberhard, D. A.; Brown, M. D.; VandenBerg, S. R. Alterations of annexin expression in pathological neuronal and glial reactions: Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am. J. Pathol. 1994, 145 (3), 640-649.
34. Liu, N.; Han, S.; Lu, P. H.; Xu, X. M. Upregulation of annexins I, II, and V after traumatic spinal cord injury in adult rats. J. Neurosci. Res. 2004, 77 (3), 391-401.
35. Nijtmans, L. G. J.; De Jong, L.; Sanz, M. A.; Coates, P. J.; Berden, J. A.; Back, J. W.; Muijsers, A. O.; Van Der Spek, H.; Grivell, L. A. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000, 19 (11), 2444-2451.
36. Liu, X.; Ren, Z.; Zhan, R.; Wang, X.; Zhang, Z.; Leng, X.; Yang, Z.; Qian, L. Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte. Cell Stress Chaperones 2008, 1-9.
37. Suh, K. S.; Mutoh, M.; Gerdes, M.; Crutchley, J. M.; Mutoh, T.; Edwards, L. E.; Dumont, R. A.; Sodha, P.; Cheng, C.; Glick, A.; Yuspa, S. H. Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor R-induced apoptosis, and inhibits tumor growth. Cancer Res. 2005, 65 (2), 562-571.
38. Schlattner, U.; Tokarska-Schlattner, M.; Wallimann, T. Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta 2006, 1762 (2), 164-180.
39. Kowara, R.; Moraleja, K. L.; Chakravarthy, B. PLA2 signaling is involved in calpain-mediated degradation of synaptic dihydropyrimidinase-like 3 protein in response to NMDA excitotoxicity. Neurosci. Lett. 2008, 430 (3), 197-202.
40. + cells. Am. J. Physiol.: Renal Physiol. 2003, 285, F258-265.
41. Zoratti, M.; Szabo, I. The mitochondrial permeability transition. Biochim. Biophys. Acta 1995, 1241 (2), 139-176.
42. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15 (22), 2922-2933.
43. Shoshan-Barmatz, V.; Israelson, A.; Brdiczka, D.; Sheu, S. S. The voltage-dependent anion channel (VDAC): Function in intracellular signalling, cell life and cell death. Curr. Pharm. Des. 2006, 12 (18), 2249-2270.
44. Zheng, Y.; Shi, Y.; Tian, C.; Jiang, C.; Jin, H.; Chen, J.; Almasan, A.; Tang, H.; Chen, Q. Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide. Oncogene 2004, 23 (6), 1239-1247.
45. Berman, S. B.; Watkins, S. C.; Hastings, T. G. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: Evidence for reduced sensitivity of brain mitochondria. Exp. Neurol. 2000, 164 (2), 415-425.
46. Eliseev, R. A.; Filippov, G.; Velos, J.; VanWinkle, B.; Goldman, A.; Rosier, R. N.; Gunter, T. E. Role of cyclophilin D in the resistance of brain mitochondria to the permeability transition. Neurobiol. Aging 2007, 28 (10), 1532-1542.
47. Schinzel, A. C.; Takeuchi, O.; Huang, Z.; Fisher, J. K.; Zhou, Z.; Rubens, J.; Hetz, C.; Danial, N. N.; Moskowitz, M. A.; Korsmeyer, S. J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (34), 12005-12010.
48. Aleyasin, H.; Rousseaux, M. W. C.; Phillips, M.; Kim, R. H.; Bland, R. J.; Callaghan, S.; Slack, R. S.; During, M. J.; Mak, T. W.; Park, D. S. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (47), 18748-18753.
49. Yanagisawa, D.; Kitamura, Y.; Inden, M.; Takata, K.; Taniguchi, T.; Morikawa, S.; Morita, M.; Inubushi, T.; Tooyama, I.; Taira, T.; Iguchi-Ariga, S. M. M.; Akaike, A.; Ariga, H. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J. Cereb. Blood Flow Metab. 2008, 28 (3), 563-578.
50. Sampayo-Reyes, A.; Zakharyan, R. A. Inhibition of human glutathione S-transferase omega by tocopherol succinate. Biomed. Pharmacother. 2006, 60 (5), 238-244.
51. Kölsch, H.; Linnebank, M.; Lütjohann, D.; Jessen, F.; Wüllner, U.; Harbrecht, U.; Thelen, K. M.; Kreis, M.; Hentschel, F.; Schulz, A.; Von Bergmann, K.; Maier, W.; Heun, R. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 2004, 63 (12), 2255-2260.
52. Kölsch, H.; Larionov, S.; Dedeck, O.; Orantes, M.; Birkenmeier, G.; Griffin, W. S. T.; Thal, D. R. Association of the glutathione S-transferase omega-1 Ala140Asp polymorphism with cerebrovascular atherosclerosis and plaque-associated interleukin-1α expression. Stroke 2007, 38 (10), 2847-2850.
53. Miller, J. A.; Oldham, M. C.; Geschwind, D. H. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J. Neurosci. 2008, 28 (6), 1410-1420.
54. Spiechowicz, M.; Bernstein, H. G.; Dobrowolny, H.; Leśniak, W.; Mawrin, C.; Bogerts, B.; Kuünicki, J.; Filipek, A. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain. Neurochem. Int. 2006, 49 (5), 487-493.
55. Salminen, A.; Suuronen, T.; Kaarniranta, K. ROCK, PAK, and Toll of synapses in Alzheimer's disease. Biochem. Biophys. Res. Commun. 2008, 371 (4), 587-590.
56. Lohoff, F. W.; Weller, A. E.; Bloch, P. J.; Nall, A. H.; Ferraro, T. N.; Berrettini, W. H. Association between polymorphisms in the vesicle-associated membrane protein-associated protein a (VAPA) gene on chromosome 18p and bipolar disorder. J. Neural Transm. 2008, 115 (9), 1339-1345.
57. Manabe, T.; Katayama, T.; Sato, N.; Gomi, F.; Hitomi, J.; Yanagita, T.; Kudo, T.; Honda, A.; Mori, Y.; Matsuzaki, S.; Imaizumi, K.; Mayeda, A.; Tohyama, M. Induced HMGA 1a expression causes aberrant splicing a Presenilin-2 pre-mRNA in sporadic Alzhiemer's disease. Cell Death Differ. 2003, 10 (6), 698-708.
58. Schurr, A. Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem. Int. 2002, 41 (1), 1-8.